TABLE 2.
Antimicrobial and category | % of isolates
|
|||
---|---|---|---|---|
Consensusa | MicroScan WalkAway | VITEK 2 | VITEK | |
Aztreonam | ||||
Susceptible | 47 | 41 | 33 | 49 |
Intermediate | 26 | 32 | 41 | 14 |
Resistant | 27 | 27 | 26 | 37 |
Cefepime | ||||
Susceptible | 59 | 39 | 57b | 44 |
Intermediate | 27 | 29 | 22 | 35 |
Resistant | 14 | 32 | 21 | 21 |
Ceftazidime | ||||
Susceptible | 44 | 43 | 44 | 42 |
Intermediate | 13 | 16 | 12 | 20 |
Resistant | 43 | 41 | 44 | 38 |
Imipenem | ||||
Susceptible | 71 | 68 | 72b | 69 |
Intermediate | 10 | 9 | 14 | 1 |
Resistant | 19 | 23 | 14 | 30 |
Piperacillin-tazobactam | ||||
Susceptible | 50 | 68 | 78b | 71 |
Resistant | 50 | 32 | 22 | 29 |
Consensus result among the broth microdilution (frozen dry-form panels), agar dilution, and disk diffusion methods.
The system did not provide results for one strain.